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615JACC Vol. 56, No. 7, 2010 Correspondence
August 10, 2010:611–5he strength of our study, we agree with Dr. Timmis, Blaha, and
cEvoy that the associated editorial to our paper took a broader
iew than our data warrants. We acknowledge the role CS has for
isk stratification in selected asymptomatic populations as well as in
pidemiologic studies of atherosclerotic disease.
Searching for surrogate evidence of stenosis, as is the case with
S, makes the performance of the test rely heavily on the
revalence of obstructive CAD and other biological factors in the
opulation it is being applied to, rendering CS unsuitable for
uling out obstructive CAD in symptomatic patients. In summary,
e believe our work reflects the application of what we know in
athophysiology to clinical medicine and supports the results of
revious studies indicating that symptomatic patients with sus-
ected CAD should not be discharged from the emergency
epartment based solely on the results of coronary calcium scores
ssessed by unenhanced CT.
We thank the colleagues who have expressed interest in our
aper and provide a forum for further discussion of the analytic and
tatistical methods used in our paper.
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eply
he 5 letters to the editor concerning the Gottlieb et al. (1) study
nd the accompanying editorial (2) all focus on what is the value ofcoronary artery calcium score (CACS) in risk prediction and the
ole of population characteristics: age, sex, and presence and type
f symptoms in determining that value.
Drs. Timmis and Correia and I all agree that the accuracy of any
iagnostic test is dependent on the population in which it is used.
Dr. McEvoy says that “the role of CS, if any,” is in “reclassifi-
ation.” I agree with him that further research is needed to
etermine if there is any value in such reclassification.
Dr. Blaha and colleagues state that the utility of CACS is “to
uide selection of appropriate pharmacotherapy.” They cite no
eferences for this speculative statement. While this is a
otential use for CACS, there are no data to suggest that
ACS has any benefit in deciding who should receive medica-
ions for hypertension or hypercholesterolemia.
However, none of the letters address the key clinical point of
hether an imaging test such as coronary artery calcium will give
s new information that leads to better patient care and improved
utcomes. Despite the use of CACS for the last 20 years, there are
till no data for either the asymptomatic or symptomatic group to
how that this information benefits our patients. That is why
he most recent U.S. Preventive Services Task Force (USPSTF)
ecommendation statement on congestive heart disease (CHD)
isk assessment concluded that “the current evidence is insufficient
o assess the balance of benefits and harms of using the nontra-
itional risk factors studied to screen asymptomatic men and
omen with no history of CHD to prevent CHD events” (3).
he USPSTF cochairs state that the critical gap in the evidence
or screening with CACS is the lack of information on
ubsequent reductions in risk for CHD events in persons
dentified by CACS (4). Before subjecting healthy men and
omen to a test with significant radiation—2 to 7 mSv (5) or
00 chest roentgenograms—one must be able to tell patients
hat there is a benefit from having this test. With no known
enefit, CACS fails this essential criteria, and the harm,
ncluding cancer risk from radiation, and incidental findings
revail.
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